Literature DB >> 17909102

Fibroblast growth factor 1 gene and hypertension: from the quantitative trait locus to positional analysis.

Maciej Tomaszewski1, Fadi J Charchar, Mark D Lynch, Sandosh Padmanabhan, William Y S Wang, William H Miller, Wladyslaw Grzeszczak, Christine Maric, Ewa Zukowska-Szczechowska, Anna F Dominiczak.   

Abstract

BACKGROUND: The distal portion of the long arm of chromosome 5 is linked to hypertension and contains functional candidate blood pressure-regulating genes. METHODS AND
RESULTS: Tightening the grid of microsatellite markers under this quantitative trait locus in the Silesian Hypertension Study (629 individuals from 207 Polish hypertensive families) provided enhanced support for linkage of this region to blood pressure (maximal Z=3.51, P=0.0002). The fine mapping, comparative genomics, and functional prioritization identified fibroblast growth factor 1 gene (FGF1) as the positional candidate. Linkage disequilibrium mapping based on 51 single nucleotide polymorphisms spanning the locus showed no overlap between 3 independent haploblocks of FGF1 and the adjacent extragenic chromosomal regions. Single and multilocus family-based analysis revealed that genetic variation within FGF1 haploblock 1 was associated with hypertension and identified a common intronic single nucleotide polymorphism, rs152524, as the major driver of this association (P=0.0026). Real-time quantitative polymerase chain reaction and Western blotting analysis of renal tissue obtained from subjects undergoing unilateral nephrectomy showed an increase in both mRNA and protein FGF1 expression in hypertensive patients compared with normotensive controls. Renal immunohistochemistry revealed that FGF1 was expressed exclusively within the glomerular endothelial and mesangial cells.
CONCLUSIONS: Our data demonstrate that genetic variation within FGF1 cosegregates with elevated blood pressure in hypertensive families and that this association is likely to be mediated by upregulation of renal FGF1 expression. The results of our study will need to be replicated in other cohorts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909102     DOI: 10.1161/CIRCULATIONAHA.107.710293

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

1.  VEGF and VEGFR1 levels in different regions of the normal and preeclampsia placentae.

Authors:  Akriti S Sahay; Anjali T Jadhav; Deepali P Sundrani; Girija N Wagh; Savita S Mehendale; Preeti Chavan-Gautam; Sadhana R Joshi
Journal:  Mol Cell Biochem       Date:  2017-08-02       Impact factor: 3.396

2.  The epithelial sodium channel γ-subunit gene and blood pressure: family based association, renal gene expression, and physiological analyses.

Authors:  Cara J Büsst; Lisa D S Bloomer; Katrina J Scurrah; Justine A Ellis; Timothy A Barnes; Fadi J Charchar; Peter Braund; Paul N Hopkins; Nilesh J Samani; Steven C Hunt; Maciej Tomaszewski; Stephen B Harrap
Journal:  Hypertension       Date:  2011-10-17       Impact factor: 10.190

3.  A common variant in low-density lipoprotein receptor-related protein 6 gene (LRP6) is associated with LDL-cholesterol.

Authors:  Maciej Tomaszewski; Fadi J Charchar; Timothy Barnes; Magdalena Gawron-Kiszka; Agnieszka Sedkowska; Ewa Podolecka; Jacek Kowalczyk; Wendy Rathbone; Zbigniew Kalarus; Wladyslaw Grzeszczak; Alison H Goodall; Nilesh J Samani; Ewa Zukowska-Szczechowska
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-10       Impact factor: 8.311

Review 4.  The emerging role of non-coding RNA in essential hypertension and blood pressure regulation.

Authors:  F Z Marques; S A Booth; F J Charchar
Journal:  J Hum Hypertens       Date:  2014-11-13       Impact factor: 3.012

5.  Pathway analysis shows association between FGFBP1 and hypertension.

Authors:  Maciej Tomaszewski; Fadi J Charchar; Christopher P Nelson; Timothy Barnes; Matthew Denniff; Michael Kaiser; Radoslaw Debiec; Paraskevi Christofidou; Suzanne Rafelt; Pim van der Harst; William Y S Wang; Christine Maric; Ewa Zukowska-Szczechowska; Nilesh J Samani
Journal:  J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 10.121

6.  Regulation of non-classical FGF1 release and FGF-dependent cell transformation by CBF1-mediated notch signaling.

Authors:  Doreen Kacer; Christian McIntire; Alek Kirov; Erin Kany; Jennifer Roth; Lucy Liaw; Deena Small; Robert Friesel; Claudio Basilico; Francesca Tarantini; Joseph Verdi; Igor Prudovsky
Journal:  J Cell Physiol       Date:  2011-11       Impact factor: 6.384

7.  FGF21 signalling pathway and metabolic traits - genetic association analysis.

Authors:  Bernhard M Kaess; Timothy A Barnes; Klaus Stark; Fadi J Charchar; Dawn Waterworth; Kijoung Song; William Y S Wang; Peter Vollenweider; Gerard Waeber; Vincent Mooser; Ewa Zukowska-Szczechowska; Nilesh J Samani; Christian Hengstenberg; Maciej Tomaszewski
Journal:  Eur J Hum Genet       Date:  2010-08-18       Impact factor: 4.246

8.  Blood Pressure Control by a Secreted FGFBP1 (Fibroblast Growth Factor-Binding Protein).

Authors:  Elena Tassi; En Yin Lai; Lingli Li; Glenn Solis; Yifan Chen; William E Kietzman; Patricio E Ray; Anna T Riegel; William J Welch; Christopher S Wilcox; Anton Wellstein
Journal:  Hypertension       Date:  2017-11-20       Impact factor: 10.190

9.  Cardiovascular Effects of Renal Distal Tubule Deletion of the FGF Receptor 1 Gene.

Authors:  Xiaobin Han; Jed Ross; Ganesh Kolumam; Min Pi; Junichiro Sonoda; Gwendalyn King; L Darryl Quarles
Journal:  J Am Soc Nephrol       Date:  2017-10-09       Impact factor: 10.121

10.  Genetic architecture of ambulatory blood pressure in the general population: insights from cardiovascular gene-centric array.

Authors:  Maciej Tomaszewski; Radoslaw Debiec; Peter S Braund; Christopher P Nelson; Robert Hardwick; Paraskevi Christofidou; Matthew Denniff; Veryan Codd; Suzanne Rafelt; Pim van der Harst; Dawn Waterworth; Kijoung Song; Peter Vollenweider; Gerard Waeber; Ewa Zukowska-Szczechowska; Paul R Burton; Vincent Mooser; Fadi J Charchar; John R Thompson; Martin D Tobin; Nilesh J Samani
Journal:  Hypertension       Date:  2010-11-08       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.